Share

    


Home / Search Results

Search Results

You searched for:

CAR T-cell therapies have ushered in a new era of treatment options for patients with certain hematologic malignancies. Thus, it is important to make these therapies accessible and affordable.
Climate change is typically seen through an environmental, political, or socioeconomic lens. Yet it should also be seen as a catastrophic health threat as it will have an effect on the delivery of comprehensive cancer care.
Virginia Cancer Research Institute successfully implemented a cutting-edge clinical trials navigation program that improved the patient and provider experience and demonstrated a significant return on investment.
Highlights from the ACCC 49th Annual Meeting and Cancer Center Business Summit.
ACCC and AstraZeneca were recognized for their joint effort in the Rural Appalachian Lung Cancer Screening Initiative at the Cancer Moonshot: Goals Forum hosted, by the President and First Lady.
Rather than fielding its annual Trending Now in Cancer Care survey while cancer programs were experiencing unprecedented challenges due to the extended public health emergency, ACCC chose to facilitate conversations with its members to capture the lived experiences of the most pertinent issues impacting oncology practice and care delivery.
This is the story of how a large independent practice in northwest Arkansas has nurtured its research program over several decades and is now able to offer patients access to phase I, II, and III trials close to home and their families.